MedTrace Logo

Efficacy and Tolerability of Buscopan Plus in Painful Gastric or Intestinal Spasms

NCT02229786 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 1637

Last updated 2014-09-01

No results posted yet for this study

Summary

Study to evaluate efficacy and tolerability of Buscopan® plus versus Buscopan®, paracetamol, and placebo in patients with painful gastric or intestinal spasms.

Conditions

  • Gastrointestinal Diseases

Interventions

DRUG

Buscopan® plus

DRUG

Buscopan®

DRUG

Paracetamol

DRUG

Placebo

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1998-02-28
Primary Completion
1999-10-31

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02229786 on ClinicalTrials.gov